Within the tumor microenvironment, tumor cells take up itaconate via the itaconate transporter SLC13A3, thereby evading immune-mediated ferroptosis through activation of the Nrf2-SLC7A11 pathway (328). The gene discussed is SLC13A3; the disease is neoplasm.